Nuklearmedizin 1977; 16(02): 86-88
DOI: 10.1055/s-0037-1620613
Originalarbeiten – Original Articles
Schattauer GmbH

Bone Marrow Scintigraphy in Patients Treated with Chemotherapy and/or Radiotherapy[*]

J. Brousil
1   From the Institute of Biophysics, Faculty of General Medicine, Charles University (Head: Prof. MUDr. Z. Dienstbier, DrSc), Prague, CSSR
,
V. Foltýnová
1   From the Institute of Biophysics, Faculty of General Medicine, Charles University (Head: Prof. MUDr. Z. Dienstbier, DrSc), Prague, CSSR
,
E. Vétrovcová
1   From the Institute of Biophysics, Faculty of General Medicine, Charles University (Head: Prof. MUDr. Z. Dienstbier, DrSc), Prague, CSSR
,
E. Tichá
1   From the Institute of Biophysics, Faculty of General Medicine, Charles University (Head: Prof. MUDr. Z. Dienstbier, DrSc), Prague, CSSR
› Author Affiliations
Further Information

Publication History

Received:09 July 1976

Publication Date:
10 January 2018 (online)

Zoom Image

Summary

Bone marrow scintigraphy after the application of indium 111 In was compared with the results of bone marrow puncture in 18 patients with Hodgkin's disease treated with radiotherapy and/or chemotherapy. Agreement was found in 85% of the cases. When the results of bone marrow puncture were compared with the general state of haemopoiesis estimated scintigraphically agreement was found in only 65%. Bone marrow scintigraphy gives a more detailed knowledge of the general state of haemopoiesis and serves as a guide for the control of therapy with cytostatics and/or irradiation.

* Dedicated to the 50th birthday anniversary of Prof. MUDr. Z. Dienstbier, DrSc, Prague